Position in GILD
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$88,811
-$9,600,188 QoQ
Shares Held
703
-99.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#2,006
of 2,265 holders
Holding Since
Mar 2021
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ascentis Independent Advisors holds $465,945 across 9 Drug Manufacturers - General names. GILD ranks #2 (19.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
778 | $195,769 | |
| 2 | GILD |
Gilead Sciences, Inc.
This page
|
703 | $88,811 | |
| 3 | NVS |
Novartis AG
|
330 | $51,717 | |
| 4 | JNJ |
Johnson & Johnson
|
175 | $44,443 | |
| 5 | MRK |
Merck & Co., Inc.
|
300 | $38,549 | |
| 6 | GSK |
GSK plc
|
697 | $36,536 | |
| 7 | SNY |
Sanofi
|
144 | $6,143 | |
| 8 | LLY |
ELI LILLY & Co
|
3 | $3,598 |
All Filings in GILD
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $88,811 | 703 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $9,688,999 | 69,520 | Shares | Sole | 2026-04-28 | |
| 2024-09-30 | $86,673 | 1,034 | Shares | Sole | 2024-10-29 | |
| 2023-12-31 | $207,709 | 2,564 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $212,005 | 2,829 | Shares | Sole | 2023-10-20 | |
| 2021-09-30 | $700,595 | 10,030 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,000,948 | 14,536 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,104,074 | 17,083 | Shares | Sole | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||